Literature DB >> 20727418

Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.

Kanchan Kohli1, Sunny Chopra, Deepika Dhar, Saurabh Arora, Roop K Khar.   

Abstract

Self-emulsifying drug delivery systems are a vital tool in solving low bioavailability issues of poorly soluble drugs. Hydrophobic drugs can be dissolved in these systems, enabling them to be administered as a unit dosage form for per-oral administration. When such a system is released in the lumen of the gastrointestinal tract, it disperses to form a fine emulsion (micro/nano) with the aid of GI fluid. This leads to in situ solubilization of drug that can subsequently be absorbed by lymphatic pathways, bypassing the hepatic first-pass effect. This article presents an exhaustive account of various literature reports on diverse types of self-emulsifying formulations with emphasis on their formulation, characterization and in vitro analysis, with examples of currently marketed preparations.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20727418     DOI: 10.1016/j.drudis.2010.08.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  53 in total

1.  The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations.

Authors:  Ahmad Abdul-Wahhab Shahba; Kazi Mohsin; Fars Kaed Alanazi
Journal:  AAPS PharmSciTech       Date:  2012-03-23       Impact factor: 3.246

2.  Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization.

Authors:  Yan Li; Jinkai Zheng; Hang Xiao; David Julian McClements
Journal:  Food Hydrocoll       Date:  2011-09-17       Impact factor: 9.147

3.  Self-nanoemulsifying drug delivery system of nifedipine: impact of hydrophilic-lipophilic balance and molecular structure of mixed surfactants.

Authors:  Yotsanan Weerapol; Sontaya Limmatvapirat; Jurairat Nunthanid; Pornsak Sriamornsak
Journal:  AAPS PharmSciTech       Date:  2014-01-23       Impact factor: 3.246

4.  Oral self-nanoemulsifying formulation of GLP-1 agonist peptide exendin-4: development, characterization and permeability assesment on Caco-2 cell monolayer.

Authors:  Merve Celik Tekeli; Yesim Aktas; Nevin Celebi
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

5.  Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers.

Authors:  Sarwar Beg; Suryakanta Swain; Harendra Pratap Singh; Ch Niranjan Patra; M E Bhanoji Rao
Journal:  AAPS PharmSciTech       Date:  2012-10-16       Impact factor: 3.246

6.  Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form.

Authors:  Sumita Singh; Kamla Pathak; Vikas Bali
Journal:  AAPS PharmSciTech       Date:  2012-09-11       Impact factor: 3.246

Review 7.  Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.

Authors:  Heejun Park; Eun-Sol Ha; Min-Soo Kim
Journal:  Pharmaceutics       Date:  2020-04-16       Impact factor: 6.321

8.  Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.

Authors:  Apurva R Patel; Ravi Doddapaneni; Terrick Andey; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  J Control Release       Date:  2015-06-14       Impact factor: 9.776

Review 9.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

10.  Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.

Authors:  Pankaj Dangre; Ritu Gilhotra; Shashikant Dhole
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.